A team from UK Trade and Investment has been appointed to sell the government’s life sciences strategy abroad.
The Life Science Investment Organisation will be led by Mark Treherne, who previously worked at Pfizer, founded Cambridge Drug Discovery and most recently ran drug company Senexis. His team of UKTI staff members is charged with drumming up business abroad by encouraging companies, universities and governments to invest in life sciences research in the UK.
This article is only available to Research Professional News subscribers or Pivot-RP users.
If you are a Research Professional News subscriber you can log in and view the article via this link
Pivot-RP users can log in and view the article via this link.